Chat with us, powered by LiveChat

Medical practices often add new techniques and procedures to increase revenue. I’m not suggesting the only reason is revenue. Presumably it’s to serve the patient and make a living BY serving the patient.

And, I’m not opposed to physicians expanding what they do from treating disease to promoting health.

But, I must admit, I did a double take when I saw the full court press on promoting vaginal rejuvenation at several recent meetings. Candidly, I knew nothing about it. My less than complete understanding is that thermal or radiofrequency energy is applied to the vaginal tissues to tighten the tissues.

The devices that are used are currently approved for removing warts or pre-cancerous cervical or vaginal tissue.

If a company wants to market a medical device or medication for a specific indication, it needs FDA approval to do so. They submit a packet describing the safety and efficacy of the intervention. Then the FDA makes a decision. Physicians are free to prescribe medications and use medical devices for indications that are not FDA approved. They must use good clinical judgment and conform to the standard of care. But, the FDA mostly addresses claims made by manufacturers when placing a drug or device into the stream of commerce.

Here’s what the FDA Commissioner, Scott Gottlieb, said in a tweet, about companies promoting equipment to address vaginal rejuvenation:

“Deceptive marketing of a dangerous procedure with no proven benefit, including to women who’ve been treated for cancer, is egregious.”

Gottlieb went on to note that the agency has reviewed patient reports and medical literature and found “numerous cases of vaginal burns, scarring, pain during sexual intercourse, and recurring or chronic pain” from the treatments.

“We’re deeply concerned women are being harmed by these procedures,” he added.

The FDA has limited oversight over physicians. But, the Board of Medicine does. Using a device for an unapproved indication may attract scrutiny. But, ultimately it comes down to whether or not the physician is following the standard of care. If the medical literature supports the use; or a critical mass of physicians are performing the technique with reasonable safety/efficacy profile, then the Board will likely be satisfied.

But, if complaints start rising; and the literature starts documenting too many side effects, expect a lawyer to start an ugly process.

Many doctors who purchase such expensive equipment just assume the literature supports its use. They also assume the FDA has approved the equipment being marketed to treat the conditions. But, if that is not the case, the new revenue center may turn out to be a bust.

What do you think?



About the Author

Jeffrey Segal, MD, JD

Dr. Jeffrey Segal, Chief Executive Officer and Founder of Medical Justice, is a board-certified neurosurgeon. In the process of conceiving, funding, developing, and growing Medical Justice, Dr. Segal has established himself as one of the country’s leading authorities on medical malpractice issues, counterclaims, and internet-based assaults on reputation.

Dr. Segal holds a M.D. from Baylor College of Medicine, where he also completed a neurosurgical residency. Dr. Segal served as a Spinal Surgery Fellow at The University of South Florida Medical School. He is a member of Phi Beta Kappa as well as the AOA Medical Honor Society. Dr. Segal received his B.A. from the University of Texas and graduated with a J.D. from Concord Law School with highest honors.

If you have a medico-legal question, write to Medical Justice at infonews@medicaljustice-staging.shfpvdx8-liquidwebsites.com.


 

  • 5
    Shares